Regenerative Medical Group provides a solution for Erectile Dysfunction (ED) and Wound (Diabetic) Healing by the use of non-invasive technology. RMG estimates that the ED market in the UK is around 5 million men and a further 5 million in the lifestyle market who are not classified as ED.
RMG, under the Vigore brand, is a healthcare service providing regenerative shockwave treatment for erectile dysfunction. Offering a long term, no side effect, no drug solution for erectile dysfunction. The same technology will be used on chronic wounds (to improve outcomes for diabetic with Chronic foot ulcers at lower cost). We operate through a licensed technology.
We partner with clinics to provide the service, avoiding direct overhead costs. As part of the partnerships the clinics provide; reception, nurses and treatment rooms. RMG trains the nurses, acquires bookings and is responsible for the marketing. The Vigore brand has been endorsed by Sir Ian Botham as the ambassador.
In addition to the ED market we have identified wound healing as a new market (the technology is already proven). We are working with an experienced NICE/NHS validation team to demonstrate its value as a treatment modality.
Current methods for wound healing are very costly and less effective than our solution. In a £5bn/year NHS spend, our method can reduce this significantly and also reduce key KPI's such as "bed blocking"
RMG reached revenues of £400k, -56k EBITDA in FY 17, and operational in 5 clinics. RMG advises that it has treated more than 450 patients to date. We are now seeking further investment to grow rapidly.
We estimate the market size for ED is between 5 and 10 million men in the UK.